Delivery Order SPE2DB22D1106-SPE2DB24FDLS7
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,598.25 firm fixed-price delivery order is for VIMPAT 200 MG TABLET UD 60S, a pharmaceutical product, with a period of performance through June 26, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract, valued at $1,181.88, is for the delivery of VIMPAT 10 MG/ML SOLUTION 200ML, a specialty medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of April 14, 2025. This award is not associated with a set-aside program. The contract appears to be part of a larger Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,301.65 firm fixed price delivery order is for the supply of VIMPAT 50 MG TABLET 60S, a prescription medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical. This IDC serves as a primary vehicle for providing...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,109.00 firm fixed-price delivery order is for VIMPAT 150 MG tablets. The contract has a 2-year period of performance, with a completion date of February 7, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,153.20 firm fixed-price delivery order is for the supply of VIMPAT 150 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of June 13, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award, valued at $1,759.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VIMPAT 100 MG TABLET 60S, a pharmaceutical product, to the government. The contract has a completion date of May 7, 2025 and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,258.70 firm fixed-price delivery order is for the supply of VIMPAT 200 MG tablets, a prescription medication used to treat epilepsy. The contract has a completion date of July 7, 2022 and was awarded on July 6, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,353.53 firm-fixed-price delivery order is for the supply of VIMPAT 200 mg tablets, with a period of performance through May 31, 2023. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,099.15, is a Firm Fixed Price Delivery Order for the supply of VIMPAT 100 MG TABLET 60S, a medication used for the treatment of epilepsy. The contract has an ultimate completion date of November 19, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,669.77 to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of VIMPAT 10 mg/mL Solution in 200 mL quantities. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive award procedures. The contract is scheduled for completion by December 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FDLS7Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,662.52 firm fixed-price delivery order is for the supply of VIMPAT 10 MG/ML SOLUTION 200ML, a specialty medication. The contract has an ultimate completion date of November 15, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order award is part of that larger IDC contract. The contract award did not utilize any set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and the company is a for-profit organization registered in the System for Award Management (SAM.gov).
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 11/14/23 |